Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. L. Serebruany
Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
FDA Urges "Black Box" Warning on Pediatric Antidepressants
CMAJ
Medicine
The Suicide Epidemic in Youth and the FDA Black-Box Warning: Time to Reconsider
Psychiatric Annals
Psychiatry
Mental Health
Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals
Infection Control and Hospital Epidemiology
Epidemiology
Infectious Diseases
Microbiology
Ticagrelor in Patients With Stable Coronary Disease and Diabetes
New England Journal of Medicine
Medicine
The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Minimal Change Disease Associated With High-Dose Aspirin
Cureus
Regional Rainfall Warning System for Landslides With Creep Deformation in Three Gorges Using a Statistical Black Box Model
Scientific Reports
Multidisciplinary
Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With NSTEMI After a 180-Mg Loading Dose
Platelets
Medicine
Hematology
Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes
JAMA - Journal of the American Medical Association
Medicine
